ntera2 d1 nt2 cell line Search Results


nt2 d1  (ATCC)
96
ATCC nt2 d1
Nt2 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nt2 d1/product/ATCC
Average 96 stars, based on 1 article reviews
nt2 d1 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

95
ATCC human tgct embryonal carcinoma ec cell lines nt2 d1
Cisplatin-resistant <t>TGCT</t> cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response <t>of</t> <t>NT2/D1</t> parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.
Human Tgct Embryonal Carcinoma Ec Cell Lines Nt2 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tgct embryonal carcinoma ec cell lines nt2 d1/product/ATCC
Average 95 stars, based on 1 article reviews
human tgct embryonal carcinoma ec cell lines nt2 d1 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
ATCC human ntera2 d1 cell line
Cisplatin-resistant <t>TGCT</t> cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response <t>of</t> <t>NT2/D1</t> parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.
Human Ntera2 D1 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ntera2 d1 cell line/product/ATCC
Average 93 stars, based on 1 article reviews
human ntera2 d1 cell line - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology nt2 cells
A, Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. B, C, Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT treated primary cortical neuronal cultures (n=4 experiments). D, Representative Western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5µM was applied for 24 hrs to be able to assess protein accumulation; n=4 experiments). E, Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n=3 experiments). Tubulin was used as internal control. F, Representative Western blot showing HSF1 protein levels in control and HSF1 siRNA treated NT2 cells to confirm siRNA knockdown of HSF1 (n=2 experiments). G, Temporal dynamics of HSPA1A mRNA levels in control and BIMU8 treated NT2 cells (n=5 experiments). H, HSPA1A mRNA levels in untreated and BIMU8 treated NT2 cells (10 µM for 10 minutes) transfected with control and HSF-1 siRNA (n=4 experiments). I, Hspa1 and Hspb1 mRNA levels in untreated and BIMU8 treated (10 µM for 10 minutes) primary cortical neuronal cultures (n=3 experiments). J, Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 minutes), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction. (n=2 experiments; 25 cells). K, SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n=5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p <0.05; **, p < 0.01 ***, p <0.001; (paired Students t-test).
Nt2 Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nt2 cells/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
nt2 cells - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

98
ATCC designation ntera 2 c1 d1
A, Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. B, C, Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT treated primary cortical neuronal cultures (n=4 experiments). D, Representative Western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5µM was applied for 24 hrs to be able to assess protein accumulation; n=4 experiments). E, Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n=3 experiments). Tubulin was used as internal control. F, Representative Western blot showing HSF1 protein levels in control and HSF1 siRNA treated NT2 cells to confirm siRNA knockdown of HSF1 (n=2 experiments). G, Temporal dynamics of HSPA1A mRNA levels in control and BIMU8 treated NT2 cells (n=5 experiments). H, HSPA1A mRNA levels in untreated and BIMU8 treated NT2 cells (10 µM for 10 minutes) transfected with control and HSF-1 siRNA (n=4 experiments). I, Hspa1 and Hspb1 mRNA levels in untreated and BIMU8 treated (10 µM for 10 minutes) primary cortical neuronal cultures (n=3 experiments). J, Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 minutes), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction. (n=2 experiments; 25 cells). K, SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n=5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p <0.05; **, p < 0.01 ***, p <0.001; (paired Students t-test).
Designation Ntera 2 C1 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/designation ntera 2 c1 d1/product/ATCC
Average 98 stars, based on 1 article reviews
designation ntera 2 c1 d1 - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

90
LGC Standards sh sy5y cell lines ntera 2 cl d1
A, Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. B, C, Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT treated primary cortical neuronal cultures (n=4 experiments). D, Representative Western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5µM was applied for 24 hrs to be able to assess protein accumulation; n=4 experiments). E, Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n=3 experiments). Tubulin was used as internal control. F, Representative Western blot showing HSF1 protein levels in control and HSF1 siRNA treated NT2 cells to confirm siRNA knockdown of HSF1 (n=2 experiments). G, Temporal dynamics of HSPA1A mRNA levels in control and BIMU8 treated NT2 cells (n=5 experiments). H, HSPA1A mRNA levels in untreated and BIMU8 treated NT2 cells (10 µM for 10 minutes) transfected with control and HSF-1 siRNA (n=4 experiments). I, Hspa1 and Hspb1 mRNA levels in untreated and BIMU8 treated (10 µM for 10 minutes) primary cortical neuronal cultures (n=3 experiments). J, Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 minutes), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction. (n=2 experiments; 25 cells). K, SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n=5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p <0.05; **, p < 0.01 ***, p <0.001; (paired Students t-test).
Sh Sy5y Cell Lines Ntera 2 Cl D1, supplied by LGC Standards, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sh sy5y cell lines ntera 2 cl d1/product/LGC Standards
Average 90 stars, based on 1 article reviews
sh sy5y cell lines ntera 2 cl d1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Chemicell gmbh polymag-tat
Target (tissue/organ), nucleic acid type, magnetic nanoparticle composition, cell lines tested in vitro, and available characteristics of magnetic field summarized from the literature data.
Polymag Tat, supplied by Chemicell gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polymag-tat/product/Chemicell gmbh
Average 90 stars, based on 1 article reviews
polymag-tat - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
LGC Promochem ntera2/cl.d1 (nt2) fibroblast cells
Target (tissue/organ), nucleic acid type, magnetic nanoparticle composition, cell lines tested in vitro, and available characteristics of magnetic field summarized from the literature data.
Ntera2/Cl.D1 (Nt2) Fibroblast Cells, supplied by LGC Promochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera2/cl.d1 (nt2) fibroblast cells/product/LGC Promochem
Average 90 stars, based on 1 article reviews
ntera2/cl.d1 (nt2) fibroblast cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Agilent technologies ntera2/d1 (nt2 cells
Target (tissue/organ), nucleic acid type, magnetic nanoparticle composition, cell lines tested in vitro, and available characteristics of magnetic field summarized from the literature data.
Ntera2/D1 (Nt2 Cells, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera2/d1 (nt2 cells/product/Agilent technologies
Average 90 stars, based on 1 article reviews
ntera2/d1 (nt2 cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

99
NSJ Bioreagents neurofilament antibody (-light) / nf-l / nefl
Target (tissue/organ), nucleic acid type, magnetic nanoparticle composition, cell lines tested in vitro, and available characteristics of magnetic field summarized from the literature data.
Neurofilament Antibody ( Light) / Nf L / Nefl, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neurofilament antibody (-light) / nf-l / nefl/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
neurofilament antibody (-light) / nf-l / nefl - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

91
NSJ Bioreagents gfap antibody / glial fibrillary acidic protein
Target (tissue/organ), nucleic acid type, magnetic nanoparticle composition, cell lines tested in vitro, and available characteristics of magnetic field summarized from the literature data.
Gfap Antibody / Glial Fibrillary Acidic Protein, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gfap antibody / glial fibrillary acidic protein/product/NSJ Bioreagents
Average 91 stars, based on 1 article reviews
gfap antibody / glial fibrillary acidic protein - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

99
NSJ Bioreagents neurofilament antibody
Target (tissue/organ), nucleic acid type, magnetic nanoparticle composition, cell lines tested in vitro, and available characteristics of magnetic field summarized from the literature data.
Neurofilament Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neurofilament antibody/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
neurofilament antibody - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

Image Search Results


Cisplatin-resistant TGCT cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response of NT2/D1 parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.

Journal: Cancers

Article Title: Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors

doi: 10.3390/cancers18040575

Figure Lengend Snippet: Cisplatin-resistant TGCT cells have a less robust transcriptional response to cisplatin compared to parental cells. ( A ) Volcano plots of the cisplatin response of 2102EP parental and three independently derived cisplatin-resistant cell derivatives. ( B ) Volcano plots of the cisplatin response of NT2/D1 parental and two independently derived cisplatin-resistant cell derivatives. ( C ) Volcano plots of the cisplatin response of 833K parental and two independently derived cisplatin-resistant cell derivatives. ( D ) Number of genes upregulated and downregulated (>1.3 fold change and an FDR < 0.01) after cisplatin treatment in indicated parental and resistant cells.

Article Snippet: The human TGCT embryonal carcinoma (EC) cell lines NT2/D1, 833K, and 2102EP were obtained from ATCC.

Techniques: Derivative Assay

p53/TFRC1/MYC target genes are associated with disease-free survival in TGCT patients. High expression of a partially overlapping subset of genes associated with p53 activation and TFRC1 and MYC repression were associated with increased disease-free survival in TGCT patients as assessed by Kaplan–Meier log-rank tests. HR, hazard ratio; CI, confidence interval.

Journal: Cancers

Article Title: Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors

doi: 10.3390/cancers18040575

Figure Lengend Snippet: p53/TFRC1/MYC target genes are associated with disease-free survival in TGCT patients. High expression of a partially overlapping subset of genes associated with p53 activation and TFRC1 and MYC repression were associated with increased disease-free survival in TGCT patients as assessed by Kaplan–Meier log-rank tests. HR, hazard ratio; CI, confidence interval.

Article Snippet: The human TGCT embryonal carcinoma (EC) cell lines NT2/D1, 833K, and 2102EP were obtained from ATCC.

Techniques: Expressing, Activation Assay

A, Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. B, C, Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT treated primary cortical neuronal cultures (n=4 experiments). D, Representative Western blot showing HSPA1A protein levels following 5-HT stimulation of NT2 cells (5µM was applied for 24 hrs to be able to assess protein accumulation; n=4 experiments). E, Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n=3 experiments). Tubulin was used as internal control. F, Representative Western blot showing HSF1 protein levels in control and HSF1 siRNA treated NT2 cells to confirm siRNA knockdown of HSF1 (n=2 experiments). G, Temporal dynamics of HSPA1A mRNA levels in control and BIMU8 treated NT2 cells (n=5 experiments). H, HSPA1A mRNA levels in untreated and BIMU8 treated NT2 cells (10 µM for 10 minutes) transfected with control and HSF-1 siRNA (n=4 experiments). I, Hspa1 and Hspb1 mRNA levels in untreated and BIMU8 treated (10 µM for 10 minutes) primary cortical neuronal cultures (n=3 experiments). J, Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 minutes), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction. (n=2 experiments; 25 cells). K, SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n=5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p <0.05; **, p < 0.01 ***, p <0.001; (paired Students t-test).

Journal: bioRxiv

Article Title: Serotonin signaling by maternal neurons upon stress ensures progeny survival

doi: 10.1101/2020.01.20.913038

Figure Lengend Snippet: A, Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. B, C, Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT treated primary cortical neuronal cultures (n=4 experiments). D, Representative Western blot showing HSPA1A protein levels following 5-HT stimulation of NT2 cells (5µM was applied for 24 hrs to be able to assess protein accumulation; n=4 experiments). E, Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n=3 experiments). Tubulin was used as internal control. F, Representative Western blot showing HSF1 protein levels in control and HSF1 siRNA treated NT2 cells to confirm siRNA knockdown of HSF1 (n=2 experiments). G, Temporal dynamics of HSPA1A mRNA levels in control and BIMU8 treated NT2 cells (n=5 experiments). H, HSPA1A mRNA levels in untreated and BIMU8 treated NT2 cells (10 µM for 10 minutes) transfected with control and HSF-1 siRNA (n=4 experiments). I, Hspa1 and Hspb1 mRNA levels in untreated and BIMU8 treated (10 µM for 10 minutes) primary cortical neuronal cultures (n=3 experiments). J, Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 minutes), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction. (n=2 experiments; 25 cells). K, SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n=5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p <0.05; **, p < 0.01 ***, p <0.001; (paired Students t-test).

Article Snippet: Control siRNA and siRNA targeting human HSF1 and SUPT16H (SPT16) were procured from Santa Cruz Biotechnology Inc, USA (catalog no. sc-37007, sc-35611 and sc-37875 respectively) and NT2 cells were transfected with Lipofectamine LTX Plus reagent according to manufacturer’s protocol.

Techniques: Control, Western Blot, Quantitation Assay, Knockdown, Transfection, Fluorescence, Immunostaining, Derivative Assay

A, Time and dose-dependent change in Hspa1a mRNA levels in control and 5-HT treated primary cortical neuronal cultures (n=4 experiments). B, Dose-dependent change in HSPA1A mRNA levels in control NT2 cells and NT2 cells treated with 5-HT for 15 minutes (n=4 experiments). C, HSPA1A mRNA levels in NT2 cells treated with 5µM 5-HT for 15 minutes, transfected with control and HSF1 siRNA (n=4 experiments). D, HSPA1A mRNA levels in NT2 cells treated with two different doses of four 5-HT receptor agonists relative to control untreated cells (n=5 experiments). NT2 cells were treated for 10 minutes. E-F, Protein levels of S320 phospho-modified HSF1 in control NT2 cells and cells treated with 10µM BIMU8 for 10 minutes, in the presence or absence of the PKA inhibitor, H89 (n=4 experiments). E, Representative western blot using an antibody that recognizes HSF1 phosphorylated at S320. Tubulin served as the internal control. F, Quantitation of phospho-S320 levels (n=4 experiments). G, Representative micrographs showing projections of confocal images of HSF1 localization in control NT2 cells and cells treated with 10µM BIMU8 for 10 minutes, in the presence or absence of the H89 (n=2 experiments; 25 cells). Scale bar=10µm. H, HSPA1A mRNA levels relative to control NT2 cells upon treatment with 10µM BIMU8 for 10 minutes, in the presence or absence of H89 (n=5 experiments). I, HSPA1A mRNA levels in cells treated with 10µM BIMU8 for 10 minutes, transfected with control and SUPT16H siRNA. mRNA levels and protein levels are normalized to control RNAi-treated or unstimulated cells (n=5 experiments). Data in A-D, F, H, I show Mean ± Standard Error of the Mean. *, p <0.05; **, p < 0.01 ***, p <0.001; (Paired Student’s t-test). ns, non-significant.

Journal: bioRxiv

Article Title: Serotonin signaling by maternal neurons upon stress ensures progeny survival

doi: 10.1101/2020.01.20.913038

Figure Lengend Snippet: A, Time and dose-dependent change in Hspa1a mRNA levels in control and 5-HT treated primary cortical neuronal cultures (n=4 experiments). B, Dose-dependent change in HSPA1A mRNA levels in control NT2 cells and NT2 cells treated with 5-HT for 15 minutes (n=4 experiments). C, HSPA1A mRNA levels in NT2 cells treated with 5µM 5-HT for 15 minutes, transfected with control and HSF1 siRNA (n=4 experiments). D, HSPA1A mRNA levels in NT2 cells treated with two different doses of four 5-HT receptor agonists relative to control untreated cells (n=5 experiments). NT2 cells were treated for 10 minutes. E-F, Protein levels of S320 phospho-modified HSF1 in control NT2 cells and cells treated with 10µM BIMU8 for 10 minutes, in the presence or absence of the PKA inhibitor, H89 (n=4 experiments). E, Representative western blot using an antibody that recognizes HSF1 phosphorylated at S320. Tubulin served as the internal control. F, Quantitation of phospho-S320 levels (n=4 experiments). G, Representative micrographs showing projections of confocal images of HSF1 localization in control NT2 cells and cells treated with 10µM BIMU8 for 10 minutes, in the presence or absence of the H89 (n=2 experiments; 25 cells). Scale bar=10µm. H, HSPA1A mRNA levels relative to control NT2 cells upon treatment with 10µM BIMU8 for 10 minutes, in the presence or absence of H89 (n=5 experiments). I, HSPA1A mRNA levels in cells treated with 10µM BIMU8 for 10 minutes, transfected with control and SUPT16H siRNA. mRNA levels and protein levels are normalized to control RNAi-treated or unstimulated cells (n=5 experiments). Data in A-D, F, H, I show Mean ± Standard Error of the Mean. *, p <0.05; **, p < 0.01 ***, p <0.001; (Paired Student’s t-test). ns, non-significant.

Article Snippet: Control siRNA and siRNA targeting human HSF1 and SUPT16H (SPT16) were procured from Santa Cruz Biotechnology Inc, USA (catalog no. sc-37007, sc-35611 and sc-37875 respectively) and NT2 cells were transfected with Lipofectamine LTX Plus reagent according to manufacturer’s protocol.

Techniques: Control, Transfection, Modification, Western Blot, Quantitation Assay

Target (tissue/organ), nucleic acid type, magnetic nanoparticle composition, cell lines tested in vitro, and available characteristics of magnetic field summarized from the literature data.

Journal: Nanomaterials

Article Title: Nonviral Locally Injected Magnetic Vectors for In Vivo Gene Delivery: A Review of Studies on Magnetofection

doi: 10.3390/nano11051078

Figure Lengend Snippet: Target (tissue/organ), nucleic acid type, magnetic nanoparticle composition, cell lines tested in vitro, and available characteristics of magnetic field summarized from the literature data.

Article Snippet: spinal cord , rat , pDNA , U87, H4, T98G, NT2 (Ntera-2/D1), U251 , PolyMag(Chemicell)-Tat , - , [ ] , 1.21.

Techniques: In Vitro